{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:24:01Z","timestamp":1789514641276,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nuclear factor-kB (NF-kB) is a crucial transcription factor in the signal transduction cascade of the inflammatory signaling. Activation of NF-\u03baB depends on the phosphorylation of I\u03baB\u03b1 by I\u03baB kinase (IKK\u03b2) followed by subsequent ubiquitination and degradation. This leads to the nuclear translocation of the p50- p65 subunits of NF-\u03baB, and further triggers pro-inflammatory cytokine gene expression. Thus, in the need of a more effective therapy for the treatment of inflammatory diseases, specific inhibition of IKK\u03b2 represents a rational alternative strategy to the current therapies. A computer-aided drug identification protocol was followed to identify novel IKK\u03b2 inhibitors from a database of over 1500 Food and Drug Administration (FDA) drugs. The best scoring compounds were compared with the already known high-potency IKK\u03b2 inhibitors for their ability to bind and inhibit IKK\u03b2 by evaluating their docking energy. Finally, Thioridazinehydrochloride (TDZ), a potent antipsychotic drug against Schizophrenia was selected and its efficiency in inhibiting I\u03baB\u03b1 protein degradation and NF-\u03baB activation was experimentally validated. Our study has demonstrated that TDZ blocks I\u03baB\u03b1 protein degradation and subsequent NF-\u03baB activation to inhibit inflammation. Thus, it is a potential repurposed drug against inflammation.<\/jats:p>","DOI":"10.1038\/s41598-018-30763-5","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T14:39:36Z","timestamp":1534257576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Repurposing Thioridazine (TDZ) as an anti-inflammatory agent"],"prefix":"10.1038","volume":"8","author":[{"given":"Mirza S.","family":"Baig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjan","family":"Rajpoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Naim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-8088","authenticated-orcid":false,"given":"Dongfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Saluja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed M.","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-6184","authenticated-orcid":false,"given":"Qiuwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Turkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanan N.","family":"Darwhekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1538-2091","authenticated-orcid":false,"given":"Rajkumar","family":"Savai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"30763_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel, B. & Schmid, J. A. The complexity of NF-\u03baB signaling in inflammation and cancer. Molecular cancer 12, 86 (2013).","journal-title":"Molecular cancer"},{"key":"30763_CR2","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus, A. & Ghosh, S. The NF-\u03baB family of transcription factors and its regulation. Cold Spring Harbor perspectives in biology 1, a000034 (2009).","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"30763_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/CMR.15.3.414-429.2002","volume":"15","author":"J Caamano","year":"2002","unstructured":"Caamano, J. & Hunter, C. A. NF-\u03baB family of transcription factors: central regulators of innate and adaptive immune functions. Clinical microbiology reviews 15, 414\u2013429 (2002).","journal-title":"Clinical microbiology reviews"},{"key":"30763_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","volume":"107","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto, Y. & Gaynor, R. B. Therapeutic potential of inhibition of the NF-\u03baB pathway in the treatment of inflammation and cancer. The Journal of clinical investigation 107, 135\u2013142 (2001).","journal-title":"The Journal of clinical investigation"},{"key":"30763_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","volume":"21","author":"S-C Sun","year":"2011","unstructured":"Sun, S.-C. Non-canonical NF-\u03baB signaling pathway. Cell research 21, 71 (2011).","journal-title":"Cell research"},{"key":"30763_CR6","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence, T. The nuclear factor NF-\u03baB pathway in inflammation. Cold Spring Harbor perspectives in biology 1, a001651 (2009).","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"30763_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai, T. & Akira, S. Signaling to NF-\u03baB by Toll-like receptors. Trends in molecular medicine 13, 460\u2013469 (2007).","journal-title":"Trends in molecular medicine"},{"key":"30763_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","volume":"1799","author":"SC Gupta","year":"2010","unstructured":"Gupta, S. C., Sundaram, C., Reuter, S. & Aggarwal, B. B. Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1799, 775\u2013787 (2010).","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms"},{"key":"30763_CR9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1476-5381.2011.01608.x","volume":"165","author":"C Gamble","year":"2012","unstructured":"Gamble, C. et al. Inhibitory kappa B Kinases as targets for pharmacological regulation. British journal of pharmacology 165, 802\u2013819 (2012).","journal-title":"British journal of pharmacology"},{"key":"30763_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/10799893.2014.980950","volume":"35","author":"F Tian","year":"2015","unstructured":"Tian, F. et al. The small-molecule inhibitor selectivity between IKK \u03b1 and IKK \u03b2 kinases in NF-\u03ba B signaling pathway. Journal of Receptors and Signal Transduction 35, 307\u2013318 (2015).","journal-title":"Journal of Receptors and Signal Transduction"},{"key":"30763_CR11","first-page":"000","volume":"17","author":"DA Sabbaha","year":"2017","unstructured":"Sabbaha, D. A. et al. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents. Anti-cancer agents in medicinal chemistry 17, 000\u2013000 (2017).","journal-title":"Anti-cancer agents in medicinal chemistry"},{"key":"30763_CR12","doi-asserted-by":"crossref","unstructured":"Craig, S. P. III & Eakin, A. E. Structure-based inhibitor design (2000).","DOI":"10.1016\/S0083-6729(00)58024-8"},{"key":"30763_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrd748","volume":"1","author":"M Pellecchia","year":"2002","unstructured":"Pellecchia, M., Sem, D. S. & W\u00fcthrich, K. NMR in drug discovery. Nature Reviews Drug Discovery 1, 211 (2002).","journal-title":"Nature Reviews Drug Discovery"},{"key":"30763_CR14","doi-asserted-by":"crossref","unstructured":"Durand, J. & Baldwin, A. In Advances in protein chemistry and structural biology Vol. 107 77\u2013115 (Elsevier, 2017).","DOI":"10.1016\/bs.apcsb.2016.11.006"},{"key":"30763_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4155\/ppa.13.31","volume":"2","author":"S Llona-Minguez","year":"2013","unstructured":"Llona-Minguez, S., Baiget, J. & Mackay, S. P. Small-molecule inhibitors of I\u03baB kinase (IKK) and IKK-related kinases. Pharmaceutical patent analyst 2, 481\u2013498 (2013).","journal-title":"Pharmaceutical patent analyst"},{"key":"30763_CR16","first-page":"168","volume":"6","author":"S Das","year":"2007","unstructured":"Das, S. & Das, D. K. Anti-inflammatory responses of resveratrol. Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy) 6, 168\u2013173 (2007).","journal-title":"Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)"},{"key":"30763_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/1871530315666150316120316","volume":"15","author":"H Inoue","year":"2015","unstructured":"Inoue, H. & Nakata, R. Resveratrol targets in inflammation. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 15, 186\u2013195 (2015).","journal-title":"Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)"},{"key":"30763_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin, J. J. & Shoichet, B. K. ZINC\u2212 a free database of commercially available compounds for virtual screening. Journal of chemical information and modeling 45, 177\u2013182 (2005).","journal-title":"Journal of chemical information and modeling"},{"key":"30763_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.6026\/97320630009583","volume":"9","author":"JK Monika","year":"2013","unstructured":"Monika, J. K. & Singh, K. Virtual screening using the ligand ZINC database for novel lipoxygenase-3 inhibitors. Bioinformation 9, 583 (2013).","journal-title":"Bioinformation"},{"key":"30763_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature09853","volume":"472","author":"G Xu","year":"2011","unstructured":"Xu, G. et al. Crystal structure of inhibitor of \u03baB kinase \u03b2. Nature 472, 325 (2011).","journal-title":"Nature"},{"key":"30763_CR21","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1021\/jm9006966","volume":"52","author":"JJ Irwin","year":"2009","unstructured":"Irwin, J. J. et al. Automated docking screens: a feasibility study. Journal of medicinal chemistry 52, 5712\u20135720 (2009).","journal-title":"Journal of medicinal chemistry"},{"key":"30763_CR22","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-4-S1-P17","volume":"4","author":"R Kiss","year":"2012","unstructured":"Kiss, R., Sandor, M. & Szalai, F. A. http:\/\/Mcule. com: a public web service for drug discovery. Journal of cheminformatics 4, P17 (2012).","journal-title":"Journal of cheminformatics"},{"key":"30763_CR23","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkr366","volume":"39","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier, A., Zoete, V. & Michielin, O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic acids research 39, W270\u2013W277 (2011).","journal-title":"Nucleic acids research"},{"key":"30763_CR24","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. Journal of computational chemistry 25, 1605\u20131612 (2004).","journal-title":"Journal of computational chemistry"},{"key":"30763_CR25","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1084\/jem.20140654","volume":"212","author":"MS Baig","year":"2015","unstructured":"Baig, M. S. et al. NOS1-derived nitric oxide promotes NF-\u03baB transcriptional activity through inhibition of suppressor of cytokine signaling-1. Journal of Experimental Medicine 212, 1725\u20131738 (2015).","journal-title":"Journal of Experimental Medicine"},{"key":"30763_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860 (2002).","journal-title":"Nature"},{"key":"30763_CR27","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan, C. N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nature immunology 6, 1191 (2005).","journal-title":"Nature immunology"},{"key":"30763_CR28","doi-asserted-by":"crossref","unstructured":"Headland, S. E. & Norling, L. V. The resolution of inlammation: Principles and challenges. Seminars in Immunology 27, 149\u2013160 (2015).","DOI":"10.1016\/j.smim.2015.03.014"},{"key":"30763_CR29","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.1152\/ajpendo.00204.2007","volume":"293","author":"CH Lang","year":"2007","unstructured":"Lang, C. H., Frost, R. A. & Vary, T. C. Regulation of muscle protein synthesis during sepsis and inflammation. American Journal of Physiology-Endocrinology and Metabolism 293, E453\u2013E459 (2007).","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"30763_CR30","unstructured":"Kaplan, M. H. (Taylor & Francis, 2013)."},{"key":"30763_CR31","doi-asserted-by":"publisher","first-page":"i109","DOI":"10.1136\/ard.2010.140533","volume":"70","author":"HB Schonthaler","year":"2011","unstructured":"Schonthaler, H. B., Guinea-Viniegra, J. & Wagner, E. F. Targeting inflammation by modulating the Jun\/AP-1 pathway. Annals of the rheumatic diseases 70, i109\u2013i112 (2011).","journal-title":"Annals of the rheumatic diseases"},{"key":"30763_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/rheumatology\/kem298","volume":"47","author":"RE Simmonds","year":"2008","unstructured":"Simmonds, R. E. & Foxwell, B. M. Signalling, inflammation and arthritis: NF-\u03ba B and its relevance to arthritis and inflammation. Rheumatology 47, 584\u2013590 (2008).","journal-title":"Rheumatology"},{"key":"30763_CR33","first-page":"346","volume":"9","author":"M Bodas","year":"2010","unstructured":"Bodas, M. & Vij, N. The NF\u03baB Signaling in Cystic Fibrosis Lung Disease: Pathophysiology and Therapeutic Potential. Discovery medicine 9, 346 (2010).","journal-title":"Discovery medicine"},{"key":"30763_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","volume":"263","author":"I Atreya","year":"2008","unstructured":"Atreya, I., Atreya, R. & Neurath, M. NF\u2010\u03baB in inflammatory bowel disease. Journal of internal medicine 263, 591\u2013596 (2008).","journal-title":"Journal of internal medicine"},{"key":"30763_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/156652309788488569","volume":"9","author":"SW Tas","year":"2009","unstructured":"Tas, S. W., Vervoordeldonk, M. J. & Tak, P. P. Gene therapy targeting nuclear factor-\u03baB: towards clinical application in inflammatory diseases and cancer. Current gene therapy 9, 160\u2013170 (2009).","journal-title":"Current gene therapy"},{"key":"30763_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak, P. P. & Firestein, G. S. NF-\u03baB: a key role in inflammatory diseases. The Journal of clinical investigation 107, 7\u201311 (2001).","journal-title":"The Journal of clinical investigation"},{"key":"30763_CR37","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S.-C. NF-\u03baB signaling in inflammation. Signal transduction and targeted therapy 2, 17023 (2017).","journal-title":"Signal transduction and targeted therapy"},{"key":"30763_CR38","doi-asserted-by":"publisher","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","volume":"2","author":"A Isra\u00ebl","year":"2010","unstructured":"Isra\u00ebl, A. The IKK complex, a central regulator of NF-\u03baB activation. Cold Spring Harbor perspectives in biology 2, a000158 (2010).","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"30763_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker, R. G., Hayden, M. S. & Ghosh, S. NF-\u03baB, inflammation, and metabolic disease. Cell metabolism 13, 11\u201322 (2011).","journal-title":"Cell metabolism"},{"key":"30763_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi, G. & Karin, M. The two NF-\u03baB activation pathways and their role in innate and adaptive immunity. Trends in immunology 25, 280\u2013288 (2004).","journal-title":"Trends in immunology"},{"key":"30763_CR41","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1073\/pnas.90.6.2532","volume":"90","author":"K Brown","year":"1993","unstructured":"Brown, K., Park, S., Kanno, T., Franzoso, G. & Siebenlist, U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proceedings of the National Academy of Sciences 90, 2532\u20132536 (1993).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"30763_CR42","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1101\/gad.7.7a.1266","volume":"7","author":"ML Scott","year":"1993","unstructured":"Scott, M. L., Fujita, T., Liou, H.-C., Nolan, G. P. & Baltimore, D. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes & development 7, 1266\u20131276 (1993).","journal-title":"Genes & development"},{"key":"30763_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrd1279","volume":"3","author":"M Karin","year":"2004","unstructured":"Karin, M., Yamamoto, Y. & Wang, Q. M. The IKK NF-\u03baB system: a treasure trove for drug development. Nature reviews Drug discovery 3, 17 (2004).","journal-title":"Nature reviews Drug discovery"},{"key":"30763_CR44","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2007.07.009","volume":"130","author":"FR Greten","year":"2007","unstructured":"Greten, F. R. et al. NF-\u03baB is a negative regulator of IL-1\u03b2 secretion as revealed by genetic and pharmacological inhibition of IKK\u03b2. Cell 130, 918\u2013931 (2007).","journal-title":"Cell"},{"key":"30763_CR45","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1002\/art.11131","volume":"48","author":"KW McIntyre","year":"2003","unstructured":"McIntyre, K. W. et al. A highly selective inhibitor of I\u03baB kinase, BMS\u2010345541, blocks both joint inflammation and destruction in collagen\u2010induced arthritis in mice. Arthritis & Rheumatology 48, 2652\u20132659 (2003).","journal-title":"Arthritis & Rheumatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30763-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30763-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30763-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:46:00Z","timestamp":1671612360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30763-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30763"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30763-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"7 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12471"}}